RBC Capital analyst Leonid Timashev lowered the price target on Nuvation Bio Inc (NYSE: NUVB) to $6.00 (from $10.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE